In this work, we report the synthesis and antileishmanial evaluation of 13 amodiaquine (AQ) derivatives (4-aminoquinoline-aryl and 4-quinolinylhydrazones series). The compounds were tested against four Leishmania species and murine macrophages. The appreciable activity of these compounds can be considered an important finding for the rational design of new leads for antileishmania compounds.
Introduction
Quinoline nucleus is a significant example of privileged structure with a wide range of biological activities including antimalarial 1, 2, 3 , antiviral 4 , antibacterial 5 , antifungal 6 , antiinflammatory 7 and antitumoral 8 . Recently activity Amodiaquine (AQ) (Figure 1 ) against different species of Leishmania sp at µM concentration has been reported 9, 10, 11 . Therefore, AQ could be considered a good start point to develop new active compounds against leishmaniasis.
In this work, we proposed the synthesis and antileishmanial evaluation of two different series of AQ analogs: 4-aminoquinoline-aryl derivatives (series a; 1-5) and 4-quinolinylhydrazones (series b; 7a-h) (Figure 1 ). Both series were designed with the conservation of 7-chloro-quinoline nucleus, however in series b the 4-amine-linker, present in AQ and in series a, was changed by a 4-hydrazone-linker. This scaffold is widely used in medicinal chemistry due to its ability in interacts with DNA by intercalation 12 , metal chelation 13 and generation of metal ion-induced radical intermediates [14] [15] [16] , which are common intracellular processes that could affect the parasite survival. 
Results and Discussion
All synthesized AQ analogs 4-aminoquinoline-aryl (1-5) and 4-quinolinylhydrazones (7a-h) derivatives were assayed against murine peritoneal macrophages and four Leishmania species promastigotes, which are three different species of Leishmania from the New World (L. braziliensis, L. chagasi and L. amazonensis) and one species from the Old World (L. major) ( 19 . The numerous of Leishmania species associated to human disease has important implications for clinical treatment and the sensitivity of each species should be considered in both experimental and clinical studies 20 . With this in mind, it is important to point that the compounds with leishmanicidal activity shown be effective against all Leishmania species tested. These results showed that in the 4-aminoquinoline-aryl derivatives (series a), the compounds 1 and 3, containing hydroxyl group in the aromatic ring, displayed a good activity against all promastigotes of Leishmania species tested. Another important observation is that the introduction of a carboxyl group in phenyl ring afforded inactive compounds (2 and 4). In this series, the compound 5 showed the best leishmanicidal activity (L. braziliensis with IC 50 value of the 4.2 µg/mL). Whereas, in the series 2, the compound 7h displayed a significant activity against promastigote forms of Leishmania species (IC 50 values of 2.4 µg/mL, 4.0 µg/mL and 19.4 µg/mL). Both compounds 5 and 7h were more effective than the AQ and they have no substituents in phenyl ring that could suggest that these compounds are very susceptible to electronic and bulk effects. Furthermore, among the thirteen compounds tested, only four compounds (4, 5, 7f and 7h) were cytotoxic against murine macrophages.
Despite the significant leishmanicidal activity, these results should be considered preliminary because the promastigotes are the extracellular form of parasite and live in the gut of the host vector 21 . Amastigote forms are found in mammalian cells and are responsible for all clinical manifestations in humans. So, the use of an intracellular assay will provide more information on the effectiveness of the compounds 21 . In addition, we performed theoretical studies of pharmacokinetic and toxicity properties using Osiris Property Explorer (http://www.organic-chemistry.org/) and Molinspiration program (http://www.molinspiration.com/cgi-bin/properties). Firstly, we calculated some important parameters, such as cLogP, molecular weight (MW), number of hydrogen bond donors (HBD) and number of hydrogen bond acceptors (HBA), which are related to the oral bioavailability, with the aim to verify if the active compounds fulfilled Lipinski ''Rule of Five'' ( Table 2) . After that, we performed a theoretical toxicity risks study (mutagenic, tumorigenic, irritant and teratogenic), which indicated low theoretical toxicity risks for all active compounds, except for the compound 1 that presented a mutagenic profile (Figure 2) . It is important to be mentioned that compounds 3, 5 and 7h presented a better profile than our prototype AQ, which is also an antimalarial drug currently in the market. Finally, we calculated the drug score values of these substances, which vary from 0 to 1 and indicate the compound's overall potential to qualify for a drug (Figure 2) . All the derivatives presented drug score values higher than the market antimalarial AQ and antiprotozoan AmB (Figure 2) , reinforcing the potential of these new prototypes as lead compounds for continuing the SAR of this class of compounds. 
Conclusion
In summary, the syntheses of a series of 4-aminoquinoline-aryl and 4-quinolinylhydrazones derivatives have been described. Some compounds have exhibited promising antileishmanial activities. Among them, derivatives 5 and 7h were more effective than the AQ, but they displayed cytotoxicity against macrophages. However, this study is important information about the structure-activity of AQ analogs and could provide a better direction in the management of antileishmanial activity and cytotoxicity in this class of compounds.
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Experimental Chemistry
The synthesis of all compounds of both series 1 and 2 started from the same precursor 4,7-dichloroquinoline. Hence, different nucleophilic displacements of the halogen present at C(4)-position are performed by several amines (series 1) or hydrazine hydrate (series 2). Firstly, the 4-aminoquinoline-aryl derivatives (1-5) (Scheme 1) were prepared in 67-93% yield by treatment of 4,7-dichloroquinoline with appropriated aromatic amines 22 ( Table 1) . In general, the 1 H NMR spectra showed the characteristic signal for the H-3 proton (shielding effect) at 6.47-6.81 ppm. Furthermore, the IR spectra showed N-H stretching vibrations at 3224-3313 cm -1 . The 7-chloro-4-quinolinylhydrazones derivatives 7a-h were previously synthesized by our research group (Scheme 1) 23 . Firstly, 7-Chloro-4-hydrazinoquinoline 6 was prepared from 4,7-dichloroquinoline using hydrazine hydrate (80%) in ethanol under reflux. After that, the compounds 7a-h were obtained through reaction between the compound 6 and appropriated benzaldehydes ( Table 1 
Cytotoxicity on macrophages
Mouse peritoneal macrophages in a concentration of 1 x 10 6 cells/mL, were plated in 96-well culture plates and incubated for 72 h at 37 o C and 5% CO 2 atmosphere. The culture medium was composed of RPMI-1640 supplemented with 10 % of fetal bovine serum and different concentrations of the tested compounds in 0.5% DMSO. The viability of the macrophages was determined with the MTT assay, as described above, and was confirmed by comparing the morphology with the control group via light microscopy.
